NCT04263779 is a NA clinical trial of Order of Options in Skilled Nursing Facilities, sponsored by Geisinger Clinic.

Who is sponsoring NCT04263779?

NCT04263779 is sponsored by Geisinger Clinic.

What drugs are being tested in NCT04263779?

Interventions in NCT04263779: Order of Options, Default Option.

What condition does NCT04263779 study?

NCT04263779 studies Skilled Nursing Facilities, Behavioral Economics.

Is NCT04263779 still recruiting?

NCT04263779 is currently completed. Last updated 2 March 2023.

Last reviewed 2023-03-02 · How we verify

NCT04263779

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Repisodic & Skilled Nursing Facility Preferred Provider Networks

Completed NA Last updated 2 March 2023

What this trial tests

NA trial testing Order of Options in Skilled Nursing Facilities in 5,581 participants. Completed in 2 January 2023.

Timeline

28 May 2021

Primary endpoint
2 January 2023

2 January 2023

Quick facts

Lead sponsor	Geisinger Clinic
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	single
Primary purpose	health services research
Enrollment	5,581
Start date	28 May 2021
Primary completion	2 January 2023
Estimated completion	2 January 2023
Sites	1 location across United States

Drugs / interventions tested

Order of Options
Default Option

Conditions studied

Skilled Nursing Facilities — all drugs for Skilled Nursing Facilities →
Behavioral Economics — all drugs for Behavioral Economics →

Sponsor

Geisinger Clinic

Who can join

18 and older, any sex, with Skilled Nursing Facilities or Behavioral Economics. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study tests whether changing the relative order of presentation of post acute care skilled nursing facilities (SNFs) in the Repisodic application, i.e., presenting preferred SNFs (P-SNFs) first, increases selection of, and discharges to, P-SNFs and decreases lengths of stay (LoS) for Geisinger patients discharged to SNFs. Along with the order of P-SNFs, the study also assesses whether a short video reviewing the benefits of care coordination in P-SNFs increases patient election to transfer to one.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Geisinger Clinic trials

Trials by the same sponsor.

NCT07197801 — Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Diso · NA · recruiting
NCT06936709 — Perioperative Colchicine for TKA · Phase 4 · not yet recruiting
NCT07042477 — Integrated Telemedicine Program Evaluation · NA · recruiting
NCT07028398 — CMSL Ambulatory Sensitive Condition Nudge Study 2 · NA · recruiting
NCT06696066 — PEERS Pilot: Peer Recovery Support Program to Support Engagement in Medication for Opioid Use Disorder · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04263779 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Geisinger Clinic
Last refreshed: 2 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04263779.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing